| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Department of Molecular Cardiology, Cleveland Clinic, Ohio.
Correspondence to Edward F. Plow, PhD, Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave/NB50, Cleveland, OH 44195. E-mail plowe{at}ccf.org
L-type Ca2+ channel (LTCC) blockers, represented by amlodipine and verapamil, are widely used antihypertensive drugs that also have antiinflammatory activities. Plasminogen (Plg) is an important mediator of macrophage recruitment, and this role depends on its interaction with Plg receptors (Plg-Rs). Plg-Rs include histone 2B,
-enolase, annexin 2, and p11, all proteins which lack signal sequences for cell surface export. When human or murine monocytoid cells were induced to differentiate into macrophages, their Plg binding and Plg-R expression increased by 4-fold. These changes were suppressed by pretreatment with verapamil and amlodipine. Expression of the Cav1.2 LTCC pore subunit was induced in differentiated macrophages, and siRNA against this subunit suppressed the upregulation of Plg binding and Plg-Rs. In vivo, amlodipine and verapamil suppressed peritoneal macrophage recruitment in response to thioglycollate by >60% at doses that did not affect blood pressure. In drug-treated animals, macrophages migrated into but not through the peritoneal membrane tissue and showed reduced surface expression of Plg-Rs. These findings demonstrate that Plg-R expression on macrophages is dependent on Cav1.2 LTCC subunit expression. Suppression of Plg-Rs may contribute to the antiinflammatory effects of the widely used LTCC blockers.
Key Words: plasminogen plasminogen receptors amlodipine verapamil macrophages
Related Article:
Circ. Res. 2009 105: 112-113.
This article has been cited by other articles:
![]() |
C. Martin, G. Gomez-Bilbao, and H. Ostolaza Bordetella Adenylate Cyclase Toxin Promotes Calcium Entry into Both CD11b+ and CD11b- Cells through cAMP-dependent L-type-like Calcium Channels J. Biol. Chem., January 1, 2010; 285(1): 357 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bkaily and D. Jacques L-Type Calcium Channel Antagonists and Suppression of Expression of Plasminogen Receptors: Is the Missing Link the L-Type Calcium Channel? Circ. Res., July 17, 2009; 105(2): 112 - 113. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |